CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 129 filers reported holding CHEMOCENTRYX INC in Q4 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $86,000 | -80.8% | 12,700 | -73.7% | 0.01% | -80.8% |
| Q2 2019 | $448,000 | +62.9% | 48,206 | +143.2% | 0.03% | +62.5% |
| Q1 2019 | $275,000 | +29.7% | 19,820 | +1.8% | 0.02% | +33.3% |
| Q4 2018 | $212,000 | -5.8% | 19,469 | +9.3% | 0.01% | +33.3% |
| Q3 2018 | $225,000 | +44.2% | 17,814 | -36.4% | 0.01% | +125.0% |
| Q3 2013 | $156,000 | -31.3% | 28,007 | +74.4% | 0.00% | -33.3% |
| Q2 2013 | $227,000 | – | 16,060 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |